Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Collier

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Rheumatology|November 13, 2018
Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registryJacob R Stever, Grant W Cannon, Chia-Chen Teng, et al.
Clinical and Experimental Rheumatology|March 5, 2015
Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2)Allan Gibofsky, Grant W Cannon, David J Harrison, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 23, 2011
Limited health literacy is a common finding in a public health hospital's rheumatology clinic and is predictive of disease severityJoel M Hirsh, Dennis J Boyle, David H Collier, et al.
Arthritis Research & Therapy|September 9, 2023
Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA RegistryDimitrios A Pappas, Jacqueline O'Brien, Lin Guo, et al.
The Journal of Rheumatology|April 16, 2022
Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA TrialPhilip J Mease, Dafna D Gladman, Joseph F Merola, et al.
Journal of Managed Care & Specialty Pharmacy|March 25, 2015
Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured populationJeffrey R Curtis, Benjamin Chastek, Laura Becker, et al.
Clinical Rheumatology|December 11, 2017
Defining and characterizing sustained remission in patients with rheumatoid arthritisJeffrey R Curtis, Mona Trivedi, Boulos Haraoui, et al.
Chest|September 11, 2010
Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertensionChristina A Meadows, Michael G Risbano, Li Zhang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 13, 2019
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III TrialPhilip J Mease, Dafna D Gladman, David H Collier, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2022
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA TrialJeffrey R Curtis, Bradley Stolshek, Paul Emery, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|November 13, 2018
Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registryJacob R Stever, Grant W Cannon, Chia-Chen Teng, et al.
Clinical and Experimental Rheumatology|March 5, 2015
Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2)Allan Gibofsky, Grant W Cannon, David J Harrison, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 23, 2011
Limited health literacy is a common finding in a public health hospital's rheumatology clinic and is predictive of disease severityJoel M Hirsh, Dennis J Boyle, David H Collier, et al.
Arthritis Research & Therapy|September 9, 2023
Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA RegistryDimitrios A Pappas, Jacqueline O'Brien, Lin Guo, et al.
The Journal of Rheumatology|April 16, 2022
Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA TrialPhilip J Mease, Dafna D Gladman, Joseph F Merola, et al.
Journal of Managed Care & Specialty Pharmacy|March 25, 2015
Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured populationJeffrey R Curtis, Benjamin Chastek, Laura Becker, et al.
Clinical Rheumatology|December 11, 2017
Defining and characterizing sustained remission in patients with rheumatoid arthritisJeffrey R Curtis, Mona Trivedi, Boulos Haraoui, et al.
Chest|September 11, 2010
Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertensionChristina A Meadows, Michael G Risbano, Li Zhang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 13, 2019
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III TrialPhilip J Mease, Dafna D Gladman, David H Collier, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2022
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA TrialJeffrey R Curtis, Bradley Stolshek, Paul Emery, et al.
Pageof 5